Trials / Unknown
UnknownNCT04584918
An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men
An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement on Total Testosterone, Sex Drive and Energy Level in Senior Men
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- Innovus Pharmaceuticals, Inc. · Industry
- Sex
- Male
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect and support the tolerance of orally ingested formulation containing Eurycoma longifolia dietary supplement (Euryco-10) on a cohort of senior men.
Detailed description
This is a single-center, single arm, open label study in senior men. This study will investigate the effect and tolerance of oral ingestion of Euryco-10. Subjects meeting all inclusion and none of the exclusion criteria will be enrolled and provided with study dietary supplement. Subjects will be instructed to take 2 capsules per day for 35 days. Administration and any adverse events will be recorded in the subject diary. At each clinic visit (Day 0, Day 21 and Day 35) the Subject will complete the AMS Questionnaire.
Conditions
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2020-10-14
- Last updated
- 2020-10-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04584918. Inclusion in this directory is not an endorsement.